Skip to content

ROXASS: sector benchmark

Where does a company stand against its sector? Every ratio over five fiscal years, with its place among its peers and what that means, ready to print for your client.

Sector benchmark

ROXASS

BE 0887.031.346
NACE 86.220, Specialist medical practice
NACE division 86, Human health activities all sizesfiscal years 2020 to 202411,004 to 23,194 sector peers per ratio

Summary

fiscal year 2024

ROXASS does better than half of its sector on 5 of the 8 ratios compared.

most favourable quarter above the median below the median least favourable quarter
Strongest points
  • Working-capital ratiobetter than 95%
  • Current ratiobetter than 90%
  • Solvencybetter than 57%
Points to watch
  • Interest coveragebetter than 12%
  • Return on equitybetter than 15%
  • Return on assetsbetter than 21%

Solvency and debt

How soundly the company is financed.
Solvency
72.8%▲2024

Solvency is above 57% of 23,194 sector peers: more favourable than the median.

Position against the sector stable since 2020.

20202021202220232024
Debt to equity
0.37▼2024

Debt to equity is below 53% of 22,851 sector peers: more favourable than the median.

Position against the sector stable since 2020.

20202021202220232024
Long-term debt ratio
0.29▼2024

The long-term debt ratio is below 53% of 11,004 sector peers: more favourable than the median.

Position against the sector stable since 2020.

20202021202220232024
Interest coverage
5.53▼2024

Interest coverage is below 88% of 22,054 sector peers: in the least favourable quarter.

Position against the sector weakening since 2020.

20202021202220232024

Liquidity

Whether it can pay its short-term bills.
Current ratio
16.81▼2024

The current ratio is above 90% of 22,867 sector peers: in the most favourable quarter.

Position against the sector stable since 2020.

20202021202220232024
Working-capital ratio
93.0%▼2024

The working-capital ratio is above 95% of 23,171 sector peers: in the most favourable quarter.

Position against the sector stable since 2020.

20202021202220232024

Profitability

What the company earns on its assets and its sales.
Return on equity
9.4%▼2024

Return on equity is below 85% of 21,737 sector peers: in the least favourable quarter.

Position against the sector stable since 2020.

20202021202220232024
Return on assets
6.9%▲2024

Return on assets is below 79% of 23,151 sector peers: in the least favourable quarter.

Position against the sector stable since 2020.

20202021202220232024

Not computable

Net margin, EBITDA margin, Gross margin, Days sales outstanding, Days payable outstanding, Days inventory. This company files the abbreviated or micro schema, in which turnover and purchases are optional; margins and credit terms therefore cannot be taken from its figures.

Source: filed annual accounts (NBB) and main activity (CBE register). Compared per fiscal year with each peer's latest statutory accounts; at least 30 peers per ratio. Prepared on 29 September 2026 via checked.be.